ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years
Jayasree Chakraborty
Matched on ORCID iD 0000-0003-4434-8861; OpenAlex author ID A5068108309. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper
Papers 8
- Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ductal adenocarcinoma: a pilot study. Co-author DOI 10.3389/fonc.2025.1584167↗
- Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer. Co-author DOI 10.1038/s41591-024-03075-7↗
- Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registration. Last author DOI 10.1117/1.jmi.10.3.036002↗
- CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspective on the Use of Radiomics. Co-author DOI 10.3390/jcm12216821↗
- Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? Co-author DOI 10.1245/s10434-022-11579-0↗
- CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00261-019-02112-1↗
- Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis. First author DOI 10.1245/s10434-017-6323-3↗
- Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients. Co-author DOI 10.1371/journal.pone.0188022↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- William R. Jarnagin · 5 shared papers, 2018–2025 · strength 0.66
- Paper Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ducta… DOI 10.3389/fonc.2025.1584167↗
- Paper Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registrati… DOI 10.1117/1.jmi.10.3.036002↗
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Natally de Souza Maciel Rocha Horvat · 3 shared papers, 2023–2025 · strength 0.57
- Paper Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ducta… DOI 10.3389/fonc.2025.1584167↗
- Paper CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspect… DOI 10.3390/jcm12216821↗
- Paper Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registrati… DOI 10.1117/1.jmi.10.3.036002↗
- Richard Kinh Gian Do · 5 shared papers, 2017–2023 · strength 0.51
- Paper Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registrati… DOI 10.1117/1.jmi.10.3.036002↗
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. DOI 10.1007/s00261-019-02112-1↗
- Vinod P. Balachandran · 4 shared papers, 2018–2025 · strength 0.48
- Paper Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ducta… DOI 10.3389/fonc.2025.1584167↗
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. DOI 10.1007/s00261-019-02112-1↗
- Michael Ian D'Angelica · 4 shared papers, 2018–2025 · strength 0.48
- Paper Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ducta… DOI 10.3389/fonc.2025.1584167↗
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. DOI 10.1007/s00261-019-02112-1↗
- Jeffrey A. Drebin · 3 shared papers, 2019–2025 · strength 0.41
- Paper Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ducta… DOI 10.3389/fonc.2025.1584167↗
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. DOI 10.1007/s00261-019-02112-1↗
- Alice Chia-Chi Wei · 2 shared papers, 2023–2025 · strength 0.39
- Paper Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ducta… DOI 10.3389/fonc.2025.1584167↗
- Paper Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registrati… DOI 10.1117/1.jmi.10.3.036002↗
- Peter J. Allen · 4 shared papers, 2017–2022 · strength 0.34
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. DOI 10.1007/s00261-019-02112-1↗
- Paper Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis. DOI 10.1245/s10434-017-6323-3↗
- Amber L. Simpson · 4 shared papers, 2017–2022 · strength 0.34
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. DOI 10.1007/s00261-019-02112-1↗
- Paper Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis. DOI 10.1245/s10434-017-6323-3↗
- T. Peter Kingham · 3 shared papers, 2018–2022 · strength 0.27
- Paper Recurrence After Resection of Pancreatic Cancer: Can Radiomics Predict Patients at Greatest Risk of Liver Metastasis? DOI 10.1245/s10434-022-11579-0↗
- Paper CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. DOI 10.1007/s00261-019-02112-1↗
- Paper Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis. DOI 10.1245/s10434-017-6323-3↗
- Eileen Mary O'Reilly · 2 shared papers, 2017–2023 · strength 0.24
- Paper Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registrati… DOI 10.1117/1.jmi.10.3.036002↗
- Paper Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients. DOI 10.1371/journal.pone.0188022↗
- Ellis L. Eikenboom · 1 shared paper, 2025 · strength 0.21
- Kevin C. Soares · 1 shared paper, 2025 · strength 0.21
- T. Peter Kingham · 1 shared paper, 2025 · strength 0.21
- Caitlin A. McIntyre · 2 shared papers, 2019–2022 · strength 0.20
- Hala Khasawneh · 1 shared paper, 2023 · strength 0.18
- Jon S. Heiselman · 1 shared paper, 2023 · strength 0.18
- Brett Logan Ecker · 1 shared paper, 2023 · strength 0.18
- Marc A. Attiyeh · 2 shared papers, 2018–2019 · strength 0.15
- Constantinos Pantelis Zambirinis · 1 shared paper, 2022 · strength 0.13
- Jian Zheng · 1 shared paper, 2022 · strength 0.13
- Olca Baştürk · 1 shared paper, 2019 · strength 0.08
- Gökçe Aşkan · 1 shared paper, 2019 · strength 0.08
- Christine A. Iacobuzio–Donahue · 1 shared paper, 2019 · strength 0.08
- Alexandre Doussot · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.